Assessing the Effect of 2D Fingerprint Filtering on ILP-Based Structure-Activity Relationships Toxicity Studies in Drug Design

被引:0
作者
Camacho, Rui [1 ]
Pereira, Max [1 ]
Costa, Vitor Santos [2 ]
Fonseca, Nuno A. [2 ]
Simoes, Carlos J. V. [3 ]
Brito, Rui M. M. [3 ]
机构
[1] Univ Porto, FEUP, LIAAD INESC Porto LA, Oporto, Portugal
[2] Univ Porto, DCC FCUP, CRACS INESC Porto LA, Oporto, Portugal
[3] Ctr Neurosci & Cell Biol, Fac Sci & Technol, Dept Chem, Coimbra, Portugal
来源
5TH INTERNATIONAL CONFERENCE ON PRACTICAL APPLICATIONS OF COMPUTATIONAL BIOLOGY & BIOINFORMATICS (PACBB 2011) | 2011年 / 93卷
关键词
PREDICTION; MUTAGENICITY;
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
The rational development of new drugs is a complex and expensive process. A myriad of factors affect the activity of putative candidate molecules in vivo and the propensity for causing adverse and toxic effects is recognised as the major hurdle behind the current "target-rich, lead-poor" scenario. Structure-Activity Relationship studies, using relational Machine Learning algorithms, proved already to be very useful in the complex process of rational drug design. However, a typical problem with those studies concerns the use of available repositories of previously studied molecules. It is quite often the case that those repositories are highly biased since they contain lots of molecules that are similar to each other. This results from the common practice where an expert chemist starts off with a lead molecule, presumed to have some potential, and then introduces small modifications to produce a set of similar molecules. Thus, the resulting sets have a kind of similarity bias. In this paper we assess the advantages of filtering out similar molecules in order to improve the application of relational learners in Structure-Activity Relationship (SAR) problems to predict toxicity. Furthermore, we also assess the advantage of using a relational learner to construct comprehensible models that may be quite valuable to bring insights into the workings of toxicity.
引用
收藏
页码:355 / +
页数:2
相关论文
共 16 条
  • [1] A novel logic-based approach for quantitative toxicology prediction
    Amini, Ata
    Muggleton, Stephen H.
    Lodhi, Huma
    Sternberg, Michael J. E.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (03) : 998 - 1006
  • [2] In silico prediction of drug toxicity
    Dearden, JC
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (02) : 119 - 127
  • [3] Virtual exploration of the small-molecule chemical universe below 160 daltons
    Fink, T
    Bruggesser, H
    Reymond, JL
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (10) : 1504 - 1508
  • [4] Accelerating the drug design process through parallel inductive logic programming data mining
    Graham, J
    Page, CD
    Kamal, A
    [J]. PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, 2003, : 400 - 402
  • [5] Blue Obelisk - Interoperability in chemical informatics
    Guha, Rajarshi
    Howard, Michael T.
    Hutchison, Geoffrey R.
    Murray-Rust, Peter
    Rzepa, Henry
    Steinbeck, Christoph
    Wegner, Jorg
    Willighagen, Egon L.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (03) : 991 - 998
  • [6] Derivation and validation of toxicophores for mutagenicity prediction
    Kazius, J
    McGuire, R
    Bursi, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) : 312 - 320
  • [7] MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequences
    Kumar, Sudhir
    Nei, Masatoshi
    Dudley, Joel
    Tamura, Koichiro
    [J]. BRIEFINGS IN BIOINFORMATICS, 2008, 9 (04) : 299 - 306
  • [8] Hybrid intelligent systems for predictive toxicology - A distributed approach
    Neagu, D
    Craciun, MV
    Stroia, SA
    Bumbaru, S
    [J]. 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, 2005, : 26 - 31
  • [9] PEREIRA M, 2009, BRAS S BIOINF
  • [10] Plewczynski Dariusz, 2008, International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies (BIOTECHNO 2008), P59, DOI 10.1109/BIOTECHNO.2008.15